BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Art Pappas will speak about future trends in biotechnology at the Charlotte Biotechnology Conference in Charlotte, NC
News | 10. 27. 2010
